HIMS Expands Into Menopause Care But Amazon’s GLP-1 Program Weighs On Stock

{
  "signal_id": "819dadb6-6ea0-db0b-d83b-7e20f2bcd621",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-07-17T13:58:49+00:00",
  "company": {
    "name": "Hims & Hers",
    "domain": "hims.com"
  },
  "data": {
    "url": "https://stocktwits.com/news-articles/markets/equity/hims-expands-into-menopause-care-but-amazon-s-glp-1-program-weighs-on-stock/cZBBDEDRebG",
    "title": "HIMS Expands Into Menopause Care But Amazon’s GLP-1 Program Weighs On Stock - Stocktwits",
    "excerpt": "Advertisement | Remove ads. Shares of Hims & Hers Health (HIMS) dropped nearly 5% on Wednesday despite the company’s expansion into perimenopause and premenopause care, as analysts raised concerns over lower 2026 revenues following Amazon’s launch of its GLP-1 program. HIMS stock is set to end its second consecutive session lower after analysts at Bank of America (BofA) raised revenue growth concerns. “Amazon's (AMZN) new offering in the GLP-1 market appears well suited for long-term GLP-1 subscribers that may opt to minimize ongoing costs, pressuring HIMS' GLP-1 revenue in 2026 and beyond,” BofA wrote in a note. The telehealth company on Wednesday ventured into menopause and perimenopause care by launching estrogen patches amid an acute shortage in the U.S. Advertisement | Remove ads. A surge in demand since last year for estrogen patches to ease menopause symptoms has strained supplies and led to shortages, sparking a scramble for medicines that industry sources say could last up to three years, according to a Reuters report. The U.S. Food and Drug Administration (FDA) last year removed safety warnings and publicly promoted hormone replacement therapy for some patients at a time when over a million women in the U.S. hit menopause each year. HIMS said it has secured sufficient inventory of estrogen patches and will be available immediately to eligible users through its Hers...",
    "product": "estrogen patches",
    "summary": "Hims & Hers Health has expanded its services to include menopause and perimenopause care, launching estrogen patches which will be available immediately through its Hers platform.",
    "location": "United States",
    "planning": false,
    "image_url": "https://news.stocktwits-cdn.com/large_Getty_Images_2227669377_jpg_9a115c3623.webp",
    "confidence": 0.9,
    "product_data": {
      "name": "estrogen patches",
      "full_text": "estrogen patches",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-07-17T13:58:49Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-07-15",
    "article_sentence": "The telehealth company on Wednesday ventured into menopause and perimenopause care by launching estrogen patches amid an acute shortage in the U.S."
  }
}

curl https://signals.autobound.ai/v1/signals/819dadb6-6ea0-db0b-d83b-7e20f2bcd621 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"hims.com","limit":20}'